1
|
Jemal A, Murray T, Ward E, Samuels A,
Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics,
2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar
|
2
|
Kim J, Takeuchi H, Lam ST, Turner RR, Wang
HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor
CXCR4 expression in colorectal cancer patients increases the risk
for recurrence and for poor survival. J Clin Oncol. 23:2744–2753.
2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gupta GP and Massague J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Steeg PS: Tumor metastasis: mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
7
|
Muller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL,
et al: Involvement of chemokine receptors in breast cancer
metastasis. Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Zlotnik A and Yoshie O: Chemokines: a new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zlotnik A: Chemokines and cancer. Int J
Cancer. 119:2026–2029. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lee JH, Cho YS, Lee JY, Kook MC, Park JW,
Nam BH and Bae JM: The chemokine receptor CCR4 is expressed and
associated with a poor prognosis in patients with gastric cancer.
Ann Surg. 249:933–941. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
|
12
|
Van Damme J, Proost P, Lenaerts JP and
Opdenakker G: Structural and functional identification of two
human, tumor-derived monocyte chemotactic proteins (MCP-2 and
MCP-3) belonging to the chemokine family. J Exp Med. 176:59–65.
1992.PubMed/NCBI
|
13
|
Uguccioni M, D’Apuzzo M, Loetscher M,
Dewald B and Baggiolini M: Actions of the chemotactic cytokines
MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human
monocytes. Eur J Immunol. 25:64–68. 1995. View Article : Google Scholar : PubMed/NCBI
|
14
|
Menten P, Proost P, Struyf S, Van Coillie
E, Put W, Lenaerts JP, Conings R, Jaspar JM, De Groote D, Billiau
A, et al: Differential induction of monocyte chemotactic protein-3
in mononuclear leukocytes and fibroblasts by interferon-alpha/beta
and interferon-gamma reveals MCP-3 heterogeneity. Eur J Immunol.
29:678–685. 1999. View Article : Google Scholar
|
15
|
Power CA, Clemetson JM, Clemetson KJ and
Wells TN: Chemokine and chemokine receptor mRNA expression in human
platelets. Cytokine. 7:479–482. 1995. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xu LL, McVicar DW, Ben-Baruch A, Kuhns DB,
Johnston J, Oppenheim JJ and Wang JM: Monocyte chemotactic
protein-3 (MCP3) interacts with multiple leukocyte receptors:
binding and signaling of MCP3 through shared as well as unique
receptors on monocytes and neutrophils. Eur J Immunol.
25:2612–2617. 1995. View Article : Google Scholar
|
17
|
Hu JY, Li GC, Wang WM, Zhu JG, Li YF, Zhou
GH and Sun QB: Transfection of colorectal cancer cells with
chemokine MCP-3 (monocyte chemotactic protein-3) gene retards tumor
growth and inhibits tumor metastasis. World J Gastroenterol.
8:1067–1072. 2002.PubMed/NCBI
|
18
|
Wang JM, Deng X, Gong W and Su S:
Chemokines and their role in tumor growth and metastasis. J Immunol
Methods. 220:1–17. 1998. View Article : Google Scholar : PubMed/NCBI
|
19
|
Fujita M, Furukawa Y, Nagasawa Y, Ogawa M
and Nakamura Y: Down-regulation of monocyte chemotactic protein-3
by activated beta-catenin. Cancer Res. 60:6683–6687.
2000.PubMed/NCBI
|
20
|
Fioretti F, Fradelizi D, Stoppacciaro A,
Ramponi S, Ruco L, Minty A, Sozzani S, Garlanda C, Vecchi A and
Mantovani A: Reduced tumorigenicity and augmented leukocyte
infiltration after monocyte chemotactic protein-3 (MCP-3) gene
transfer: perivascular accumulation of dendritic cells in
peritumoral tissue and neutrophil recruitment within the tumor. J
Immunol. 161:342–346. 1998.
|
21
|
Rubie C, Oliveira V, Kempf K, Wagner M,
Tilton B, Rau B, Kruse B, Konig J and Schilling M: Involvement of
chemokine receptor CCR6 in colorectal cancer metastasis. Tumour
Biol. 27:166–174. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ghadjar P, Coupland SE, Na IK, Noutsias M,
Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C and
Keilholz U: Chemokine receptor CCR6 expression level and liver
metastases in colorectal cancer. J Clin Oncol. 24:1910–1916. 2006.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Rubie C, Frick VO, Wagner M, Weber C,
Kruse B, Kempf K, Konig J, Rau B and Schilling M: Chemokine
expression in hepatocellular carcinoma versus colorectal liver
metastases. World J Gastroenterol. 12:6627–6633. 2006.PubMed/NCBI
|
24
|
Bar-Shavit Z: The osteoclast: a
multinucleated, hematopoietic-origin, bone-resorbing osteoimmune
cell. J Cell Biochem. 102:1130–1139. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Morrison C, Mancini S, Cipollone J,
Kappelhoff R, Roskelley C and Overall C: Microarray and proteomic
analysis of breast cancer cell and osteoblast co-cultures: role of
osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J
Biol Chem. 286:34271–34285. 2011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jung DW, Che ZM and Kim J, Kim K, Kim KY,
Williams D and Kim J: Tumor-stromal crosstalk in invasion of oral
squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer.
127:332–344. 2010.PubMed/NCBI
|